fda approved glp-1 Approves First Generic Weight Loss Drug FDA Approves Generic GLP-1 Medicine

The FDAs approval was based on results from the Phase III CheckMate901 trial, where the combo regimen demonstrated a statistically significant improvement in overall survival and progression-free survival compared to cisplatin-gemcitabine alone, BMS reported

Zepbounds price has fallen to $349$499 per month. Competition has intensified as insurers respond to rising utilization, sometimes switching patients to second-choice drugs. Meanwhile, supply shortages have eased

doi: 10.1016/j.jdent.2025.105848 152 NegrutR

In the present study, we developed a low-carnitine Nile tilapia model by treating fish with a carnitine synthesis inhibitor, and used this model to investigate the functional differences between l- and d-carnitine in nutrient metabolism in fish

Register for the webinar today by clicking here .